{"id":"W2809573217","doi":"10.2337/db18-1096-p","title":"Patient-Reported Outcomes following Initiation of Glucagon-Like Peptide-1 Receptor AgonistS (GLP–1RA) in PatientS with Type 2 Diabetes—PROGRESS-DIABETES Study","year":2018,"lang":"en","type":"article","venue":"Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liraglutide; Type 2 diabetes; Internal medicine; Diabetes mellitus; Weight loss; Dulaglutide; Glucagon-like peptide 1 receptor; Interim analysis; Clinical trial; Physical therapy; Obesity; Endocrinology; Agonist","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457878,0.0005027247,0.0006312152,0.0005445116,0.0005261721,0.001025986,0.00058075,0.0006379274,0.0007551278],"category_scores_gemma":[0.002153229,0.0003397287,0.001069056,0.0009184224,0.0002515058,0.000762852,0.0006608759,0.001157006,0.0002767483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005505174,"about_ca_system_score_gemma":0.0004712514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008609627,"about_ca_topic_score_gemma":0.01133827,"domain_scores_codex":[0.9991605,0.0002264518,0.00009625743,0.0001865819,0.0002031276,0.0001270713],"domain_scores_gemma":[0.997929,0.0001641514,0.001051162,0.0001792722,0.0002636489,0.0004127802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001068775,0.0002363548,0.9970275,0.00002068168,0.0001972005,0.00006017613,0.00007314365,0.00004089954,0.0001370547,0.000008656406,0.0001244729,0.00100515],"study_design_scores_gemma":[0.0001066736,0.0007133211,0.9985744,0.000005577876,0.00008121866,0.0001027055,0.0001039132,0.00009128037,0.00003544991,0.000007177457,0.0001716956,0.000006698265],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981326,0.000140539,0.00004226472,0.00002480386,0.000007361961,0.00004147207,0.001255001,0.00000311056,0.0003528476],"genre_scores_gemma":[0.9966106,0.0001188863,0.0001097244,0.0000384391,0.00002080698,0.00004932676,0.002752753,0.000002794226,0.0002966642],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008609627,"threshold_uncertainty_score":0.01711899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01136459985142753,"score_gpt":0.2566469624209649,"score_spread":0.2452823625695374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}